Getinge AB (publ)
General ticker "GNGBF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $6.0B (TTM average)
Getinge AB (publ) follows the US Stock Market performance with the rate: 5.2%.
Estimated limits based on current volatility of 0.0%: low 20.05$, high 20.05$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-23, amount 0.52$ (Y2.59%)
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.69$, 22.09$]
- 2025-12-31 to 2026-12-31 estimated range: [12.57$, 21.89$]
Financial Metrics affecting the GNGBF estimates:
- Positive: with PPE of 28.3 at the end of fiscal year the price was low
- Positive: 6.59 < Operating cash flow per share per price, % of 9.73
- Positive: 7.54 < Operating profit margin, % of 8.21
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 2.50
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Positive: 42.59 < Shareholder equity ratio, % of 51.64 <= 64.29
- Negative: Industry earnings per price (median), % of -4.62 <= 0
- Negative: Inventory ratio change, % of 4.86 > 0.78
Short-term GNGBF quotes
Long-term GNGBF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK28,291.00MM | SEK31,827.00MM | SEK34,759.00MM |
| Operating Expenses | SEK24,665.00MM | SEK28,091.00MM | SEK31,905.00MM |
| Operating Income | SEK3,626.00MM | SEK3,736.00MM | SEK2,854.00MM |
| Non-Operating Income | SEK-154.00MM | SEK-393.00MM | SEK-572.00MM |
| Interest Expense | SEK205.00MM | SEK469.00MM | SEK606.00MM |
| R&D Expense | SEK1,185.00MM | SEK1,696.00MM | SEK1,431.00MM |
| Income(Loss) | SEK3,472.00MM | SEK3,343.00MM | SEK2,282.00MM |
| Taxes | SEK956.00MM | SEK915.00MM | SEK628.00MM |
| Net Income(Loss)* | SEK2,491.00MM | SEK2,412.00MM | SEK1,638.00MM |
| Stockholders Equity | SEK30,038.00MM | SEK30,166.00MM | SEK33,005.00MM |
| Inventory | SEK6,232.00MM | SEK6,416.00MM | SEK6,590.00MM |
| Assets | SEK52,032.00MM | SEK53,586.00MM | SEK63,918.00MM |
| Operating Cash Flow | SEK3,367.00MM | SEK2,957.00MM | SEK4,577.00MM |
| Capital expenditure | SEK1,136.00MM | SEK1,353.00MM | SEK1,309.00MM |
| Investing Cash Flow | SEK-1,470.00MM | SEK-6,543.00MM | SEK-4,549.00MM |
| Financing Cash Flow | SEK-500.00MM | SEK511.00MM | SEK504.00MM |
| Earnings Per Share** | SEK9.15 | SEK8.86 | SEK6.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.